{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:40:46Z","timestamp":1791916846874,"version":"4.3.4"},"reference-count":133,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Male hypogonadism, which is characterized by low testosterone levels, has a significant impact on male sexual function, overall health, and fertility. Testosterone replacement therapy (TRT) is the conventional treatment for this condition, but it has potential adverse effects and is not suitable for men seeking to conceive. Testosterone plays an essential role in male sexual function, metabolism, mood, and overall well-being. Clomiphene citrate, a drug originally developed for female infertility, has recently gained attention as an off-label treatment for male hypogonadism. By blocking the negative feedback of estrogen on the hypothalamus and pituitary glands, clomiphene stimulates gonadotropin secretion, leading to increased endogenous testosterone production, which, in turn, improves sperm parameters and fertility and alleviates the symptoms of hypogonadism. Regarding the safety profile of clomiphene compared with TRT, clomiphene appears to confer a lower risk than TRT, which is associated with adverse effects such as polycythemia. Furthermore, combination therapy with clomiphene and anastrozole or human chorionic gonadotropin has been investigated as a potential approach to enhancing the effectiveness of treatments for improving hypogonadism symptoms. In conclusion, clomiphene citrate may offer a promising alternative to TRT for men with hypogonadism, particularly those desiring fertility preservations. However, its long-term efficacy and safety remain inadequately understood. Future research should focus on exploring the benefits of combination therapies and personalized treatment strategies based on individual patient characteristics.<\/jats:p>","DOI":"10.3390\/ph17091233","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T03:34:20Z","timestamp":1726716860000},"page":"1233","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications"],"prefix":"10.3390","volume":"17","author":[{"given":"Yao-Cheng","family":"Wu","sequence":"first","affiliation":[{"name":"School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2375-0029","authenticated-orcid":false,"given":"Wen-Wei","family":"Sung","sequence":"additional","affiliation":[{"name":"School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"},{"name":"Department of Urology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"},{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and Management of Testosterone Deficiency: AUA Guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J. Urol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men","volume":"363","author":"Wu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","article-title":"Male hypogonadism","volume":"383","author":"Basaria","year":"2014","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1210\/jc.2003-031719","article-title":"Prevalence and Incidence of Androgen Deficiency in Middle-Aged and Older Men: Estimates from the Massachusetts Male Aging Study","volume":"89","author":"Araujo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_6","unstructured":"Salonia, A., Bettocchi, C., Capogrosso, P., Carvalho, J., Corona, G., Hatzichristodoulou, G., Jones, T.H., Kadioglu, A., Martinez-Salamanca, J.I., and Minhas, S. (2023). EAU Guidelines. The EAU Annual Congress Milan, EAU Guidelines Office."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-019-0087-y","article-title":"Paediatric and adult-onset male hypogonadism","volume":"5","author":"Salonia","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1210\/jc.2007-1245","article-title":"Prevalence of Symptomatic Androgen Deficiency in Men","volume":"92","author":"Araujo","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/andr.274","article-title":"Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men","volume":"2","author":"Zarotsky","year":"2014","journal-title":"Andrology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2796.2006.01637.x","article-title":"Low testosterone levels are associated with carotid atherosclerosis in men","volume":"259","author":"Svartberg","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/obr.12282","article-title":"Testosterone and obesity","volume":"16","author":"Kelly","year":"2015","journal-title":"Obes. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","article-title":"Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes","volume":"89","author":"Dhindsa","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1210\/jc.2016-1645","article-title":"Testosterone Treatment and Sexual Function in Older Men with Low Testosterone Levels","volume":"101","author":"Cunningham","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.eururo.2017.03.032","article-title":"Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores","volume":"72","author":"Corona","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/andr.12867","article-title":"Testosterone, mood, behaviour and quality of life","volume":"8","author":"Zitzmann","year":"2020","journal-title":"Andrology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrendo.2013.73","article-title":"Risks and benefits of testosterone therapy in older men","volume":"9","author":"Spitzer","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_17","first-page":"3578","article-title":"Testosterone replacement therapy improves mood in hypogonadal men\u2014A clinical research center study","volume":"81","author":"Wang","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","first-page":"106","article-title":"Exogenous testosterone: A preventable cause of male infertility","volume":"2","author":"Crosnoe","year":"2013","journal-title":"Transl. Androl. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-70-3-792","article-title":"Testosterone Replacement Therapy and Sleep-Related Erections in Hypogonadal Men","volume":"70","author":"Cunningham","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.juro.2016.10.068","article-title":"A Comparison of Secondary Polycythemia in Hypogonadal Men Treated with Clomiphene Citrate versus Testosterone Replacement: A Multi-Institutional Study","volume":"197","author":"Wheeler","year":"2017","journal-title":"J. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xu, L., Freeman, G., Cowling, B.J., and Schooling, C.M. (2013). Testosterone therapy and cardiovascular events among men: A systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med., 11.","DOI":"10.1186\/1741-7015-11-108"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Finkle, W.D., Greenland, S., Ridgeway, G.K., Adams, J.L., Frasco, M.A., Cook, M.B., Fraumeni, J.F., and Hoover, R.N. (2014). Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085805"},{"key":"ref_24","first-page":"759","article-title":"Re: Testosterone Products: Drug Safety Communication\u2014FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke","volume":"194","author":"Seftel","year":"2015","journal-title":"J. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.fertnstert.2012.10.023","article-title":"Aromatase inhibitors for male infertility","volume":"98","author":"Schlegel","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0015-0282(16)56705-3","article-title":"Tamoxifen treatment in male infertility. I. Effect on spermatozoa","volume":"61","author":"Kotoulas","year":"1994","journal-title":"Fertil. Steril."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/2.6.483","article-title":"Development, pharmacology and clinical experience with clomiphene citrate","volume":"2","author":"Dickey","year":"1996","journal-title":"Hum. Reprod. Update"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.euf.2018.07.033","article-title":"Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male","volume":"4","author":"Scovell","year":"2018","journal-title":"Eur. Urol. Focus."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.fertnstert.2014.06.004","article-title":"Enclomiphene citrate stimulates testosterone production while preventing oligospermia: A randomized phase II clinical trial comparing topical testosterone","volume":"102","author":"Wiehle","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/andr.13388","article-title":"Clomiphene citrate for male infertility: A systematic review and meta-analysis","volume":"11","author":"Huijben","year":"2023","journal-title":"Andrology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1196\/annals.1336.023","article-title":"The Androgen Microenvironment of the Human Testis and Hormonal Control of Spermatogenesis","volume":"1061","author":"Jarow","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/JU.0000000000000396","article-title":"Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism","volume":"202","author":"Krzastek","year":"2019","journal-title":"J. Urol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1743-6109.2009.01454.x","article-title":"Clomiphene Citrate and Testosterone Gel Replacement Therapy for Male Hypogonadism: Efficacy and Treatment Cost","volume":"7","author":"Taylor","year":"2010","journal-title":"J. Sex. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ucl.2016.01.001","article-title":"Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male","volume":"43","author":"Corradi","year":"2016","journal-title":"Urol. Clin. N. Am."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2014.08.048","article-title":"Molecular regulation of hypothalamus\u2013pituitary\u2013gonads axis in males","volume":"551","author":"Jin","year":"2014","journal-title":"Gene"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000123540","article-title":"Control of pulsatile LH release in male rats","volume":"37","author":"Ellis","year":"1983","journal-title":"Neuroendocrinology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/edrv.23.2.0462","article-title":"The lutropin\/choriogonadotropin receptor, a 2002 perspective","volume":"23","author":"Ascoli","year":"2002","journal-title":"Endocr. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2008.07.016","article-title":"Leydig cell aging and the mechanisms of reduced testosterone synthesis","volume":"299","author":"Midzak","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr. Rev."},{"key":"ref_40","first-page":"2578","article-title":"Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans","volume":"82","author":"Young","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jsbmb.2008.03.004","article-title":"Hormonal regulation of spermatogenesis and spermiogenesis","volume":"109","author":"Sofikitis","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/scdb.1998.0203","article-title":"The central role of Sertoli cells in spermatogenesis","volume":"9","author":"Griswold","year":"1998","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrurol.2016.62","article-title":"Diagnosis and treatment of infertility-related male hormonal dysfunction","volume":"13","author":"Kathrins","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"ref_44","first-page":"2314","article-title":"Testosterone regulates apoptosis in adult human seminiferous tubules in vitro","volume":"82","author":"Hirvonen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1093\/humrep\/16.12.2640","article-title":"Assisted reproduction with in-vitro-cultured testicular spermatozoa in cases of severe germ cell apoptosis: A pilot study","volume":"16","author":"Tesarik","year":"2001","journal-title":"Hum. Reprod."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrurol.2009.235","article-title":"The role of testosterone in erectile dysfunction","volume":"7","author":"Corona","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrurol.2018.20","article-title":"Sexual dysfunction and male infertility","volume":"15","author":"Lotti","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/2042018810390258","article-title":"Testosterone and the metabolic syndrome","volume":"1","author":"Muraleedharan","year":"2010","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_49","first-page":"1610","article-title":"Relationship of sex hormones to lipids and lipoproteins in nondiabetic men","volume":"77","author":"Haffner","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2005.02299.x","article-title":"Androgens, insulin resistance and vascular disease in men","volume":"63","author":"Kapoor","year":"2005","journal-title":"Clin. Endocrinol."},{"key":"ref_51","first-page":"3673","article-title":"Leptin and androgens in male obesity: Evidence for leptin contribution to reduced androgen levels","volume":"84","author":"Isidori","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-71-4-929","article-title":"Plasma Free and Non-Sex-Hormone-Binding-Globulin Bound Testosterone Are Decreased in Obese Men in Proportion to Their Degree of Obesity","volume":"71","author":"Zumoff","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/jc.2010-2724","article-title":"Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity","volume":"96","author":"Dandona","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2826.2001.00632.x","article-title":"The In Vitro Role of Tumour Necrosis Factor-Alpha and Interleukin-6 in the Hypothalamic-Pituitary Gonadal Axis","volume":"13","author":"Russell","year":"2001","journal-title":"J. Neuroendocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1210\/en.2003-0644","article-title":"Hypothalamic Interleukin-1\u03b2 and Tumor Necrosis Factor-\u03b1, But Not Interleukin-6, Mediate the Endotoxin-Induced Suppression of the Reproductive Axis in Rats","volume":"144","author":"Watanobe","year":"2003","journal-title":"Endocrinology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1742-1241.2010.02355.x","article-title":"A practical guide to male hypogonadism in the primary care setting","volume":"64","author":"Dandona","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/dc15-1518","article-title":"Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes","volume":"39","author":"Dhindsa","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e015284","DOI":"10.1136\/bmjopen-2016-015284","article-title":"Testosterone therapy in hypogonadal men: A systematic review and network meta-analysis","volume":"7","author":"Elliott","year":"2017","journal-title":"BMJ Open"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3949\/ccjm.79a.11174","article-title":"Male hypogonadism: More than just a low testosterone","volume":"79","author":"Pantalone","year":"2012","journal-title":"Cleve Clin. J. Med."},{"key":"ref_60","first-page":"S3","article-title":"Diagnosis of hypogonadism: Clinical assessments and laboratory tests","volume":"6","author":"Carnegie","year":"2004","journal-title":"Rev. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4103\/0110-5558.72420","article-title":"Male hypogonadism: Symptoms and treatment","volume":"1","author":"Kumar","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ucl.2016.01.002","article-title":"Hypogonadism: Its Prevalence and Diagnosis","volume":"43","author":"Ross","year":"2016","journal-title":"Urol. Clin. N. Am."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/obr.12863","article-title":"Obesity and male hypogonadism: Tales of a vicious cycle","volume":"20","author":"Carrageta","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2013). Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil. Steril., 99, 63.","DOI":"10.1016\/j.fertnstert.2012.09.023"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beem.2010.08.006","article-title":"Male infertility: Pathogenesis and clinical diagnosis","volume":"25","author":"Krausz","year":"2011","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)03105-9","article-title":"Best practice policies for male infertility","volume":"77","author":"Sharlip","year":"2002","journal-title":"Fertil. Steril."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1210\/clinem\/dgaa781","article-title":"Male infertility due to testicular disorders","volume":"106","author":"Sharma","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.sxmr.2018.11.005","article-title":"Testosterone Replacement Therapy for Sexual Symptoms","volume":"7","author":"Rastrelli","year":"2019","journal-title":"Sex. Med. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1210\/er.2017-00234","article-title":"Lessons From the Testosterone Trials","volume":"39","author":"Snyder","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone Treatment and Mortality in Men with Low Testosterone Levels","volume":"97","author":"Shores","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/humupd\/dmab036","article-title":"Clinical application of aromatase inhibitors to treat male infertility","volume":"28","author":"Yang","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/andr.12126","article-title":"Effects of aromatase inhibition vs. testosterone in older men with low testosterone: Randomized-controlled trial","volume":"4","author":"Dias","year":"2016","journal-title":"Andrology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000464043","article-title":"Tamoxifen and kallikrein in therapy of oligoasthenozoospermia: Results of a randomized study","volume":"17","author":"Maier","year":"1990","journal-title":"Eur. Urol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000473006","article-title":"Tamoxifen and testolactone in therapy of oligozoospermia: Results of a randomized study","volume":"14","author":"Maier","year":"1988","journal-title":"Eur. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0015-0282(16)59299-1","article-title":"Tamoxifen citrate therapy in male infertility","volume":"48","author":"AinMelk","year":"1987","journal-title":"Fertil. Steril."},{"key":"ref_76","first-page":"15","article-title":"Empirical medical therapy for idiopathic male infertility","volume":"1","author":"Thaker","year":"2020","journal-title":"F S Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)48069-6","article-title":"Clomiphene citrate: Mechanism(s) and site(s) of action\u2014A hypothesis revisited*","volume":"42","author":"Wallach","year":"1984","journal-title":"Fertil. Steril."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/3.4.359","article-title":"Modern use of clomiphene citrate in induction of ovulation","volume":"3","author":"Kousta","year":"1997","journal-title":"Hum. Reprod. Update"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/oxfordjournals.humrep.a137165","article-title":"Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth","volume":"5","author":"Gonen","year":"1990","journal-title":"Hum. Reprod."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1743-6109.2005.00075.x","article-title":"Clomiphene Citrate Effects on Testosterone\/Estrogen Ratio in Male Hypogonadism","volume":"2","author":"Shabsigh","year":"2005","journal-title":"J. Sex. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.juro.2014.03.089","article-title":"Testosterone Supplementation Versus Clomiphene Citrate for Hypogonadism: An Age Matched Comparison of Satisfaction and Efficacy","volume":"192","author":"Ramasamy","year":"2014","journal-title":"J. Urol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jsm.12944","article-title":"A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men","volume":"12","author":"Helo","year":"2015","journal-title":"J. Sex. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0015-0282(16)47300-0","article-title":"Comparison of the effectiveness of placebo, clomiphene citrate, mesterolone, pentoxifylline, and testosterone rebound therapy for the treatment of idiopathic oligospermia","volume":"40","author":"Wang","year":"1983","journal-title":"Fertil. Steril."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/humupd\/6.3.212","article-title":"A pharmacological review of selective oestrogen receptor modulators","volume":"6","author":"Goldstein","year":"2000","journal-title":"Hum. Reprod. Update"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.fertnstert.2013.09.003","article-title":"Testosterone use in the male infertility population: Prescribing patterns and effects on semen and hormonal parameters","volume":"101","author":"Samplaski","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/j.1939-4640.1994.tb01674.x","article-title":"The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol","volume":"15","author":"Bagatell","year":"1994","journal-title":"J. Androl."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/jcem-52-5-897","article-title":"Effects of delta 1-testolactone on the pituitary-testicular axis in oligospermic men","volume":"52","author":"Vigersky","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1439-0272.1986.tb01741.x","article-title":"Effect of chronic aromatase inhibition by delta 1-testolactone on pituitary-gonadal function in oligozoospermic men","volume":"18","author":"Dony","year":"1986","journal-title":"Andrologia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/j.1939-4640.1989.tb00094.x","article-title":"Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover","volume":"10","author":"Clark","year":"1989","journal-title":"J. Androl."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0022-5347(05)66540-8","article-title":"Evidence of a treatable endocrinopathy in infertile men","volume":"165","author":"Pavlovich","year":"2001","journal-title":"J. Urol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.fertnstert.2010.09.021","article-title":"The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men","volume":"95","author":"Saylam","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/meta.2000.8625","article-title":"Validation of a screening questionnaire for androgen deficiency in aging males","volume":"49","author":"Morley","year":"2000","journal-title":"Metabolism"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.maturitas.2005.07.004","article-title":"Comparison of screening questionnaires for the diagnosis of hypogonadism","volume":"53","author":"Morley","year":"2006","journal-title":"Maturitas"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ijir.2009.35","article-title":"The quantitative ADAM questionnaire: A new tool in quantifying the severity of hypogonadism","volume":"22","author":"Mohamed","year":"2010","journal-title":"Int. J. Impot. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1464-410X.2011.10702.x","article-title":"Outcomes of clomiphene citrate treatment in young hypogonadal men","volume":"110","author":"Katz","year":"2012","journal-title":"BJU Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/bju.13546","article-title":"Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels","volume":"118","author":"Chandrapal","year":"2016","journal-title":"BJU Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2012.10968.x","article-title":"Clomiphene citrate is safe and effective for long-term management of hypogonadism","volume":"110","author":"Moskovic","year":"2012","journal-title":"BJU Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/bju.14401","article-title":"Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: A short-course randomized study","volume":"122","author":"Habous","year":"2018","journal-title":"BJU Int."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41366-018-0105-2","article-title":"Effects of clomiphene citrate on male obesity-associated hypogonadism: A randomized, double-blind, placebo-controlled study","volume":"42","author":"Soares","year":"2018","journal-title":"Int. J. Obes."},{"key":"ref_100","first-page":"3546","article-title":"Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo-controlled trial with clomiphene citrate","volume":"80","author":"Guay","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.ijir.3900981","article-title":"Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: Who does and does not benefit?","volume":"15","author":"Guay","year":"2003","journal-title":"Int. J. Impot. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"9649838","DOI":"10.1155\/2020\/9649838","article-title":"Is There Room for SERMs or SARMs as Alternative Therapies for Adult Male Hypogonadism?","volume":"2020","author":"Giagulli","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Ide, V., Vanderschueren, D., and Antonio, L. (2020). Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010021"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2605.2004.00502.x","article-title":"Hormonal regulation of spermatogenesis","volume":"27","author":"Holdcraft","year":"2004","journal-title":"Int. J. Androl."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2605.1980.tb00136.x","article-title":"The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: A controlled double-blind cross-over study","volume":"3","year":"1980","journal-title":"Int. J. Androl."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejogrb.2019.05.011","article-title":"Clomiphene citrate effect on testosterone level and semen parameters in 18 infertile men with low testosterone level and normal\/low gonadotropines level","volume":"238","author":"Surbone","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0022-5347(17)48889-6","article-title":"Evaluation of sperm parameters in clinical trial with clomiphene citrate of oligospermic men","volume":"133","year":"1985","journal-title":"J. Urol."},{"key":"ref_108","first-page":"188","article-title":"Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: A comparative study","volume":"7","author":"Moradi","year":"2010","journal-title":"Urol. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2605.1992.tb01129.x","article-title":"A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility","volume":"15","author":"Rowe","year":"1992","journal-title":"Int. J. Androl."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.2047-2927.2013.00107.x","article-title":"Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: A meta-analysis","volume":"1","author":"Chua","year":"2013","journal-title":"Andrology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0015-0282(16)59898-7","article-title":"A controlled comparison of the efficacy of clomiphene citrate in male infertility","volume":"49","author":"Sokol","year":"1988","journal-title":"Fertil. Steril."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/andr.13146","article-title":"Clomiphene citrate for men with hypogonadism: A systematic review and meta-analysis","volume":"10","author":"Huijben","year":"2022","journal-title":"Andrology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.sxmr.2018.10.001","article-title":"Clomiphene Citrate for the Treatment of Hypogonadism","volume":"7","author":"Wheeler","year":"2019","journal-title":"Sex. Med. Rev."},{"key":"ref_114","first-page":"e7","article-title":"Clomiphene citrate-induced severe hypertriglyceridemia","volume":"92","year":"2009","journal-title":"Fertil. Steril."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4065\/74.11.1125","article-title":"Clomiphene-induced severe hypertriglyceridemia and pancreatitis","volume":"74","author":"Castro","year":"1999","journal-title":"Mayo Clin. Proc."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1590\/S1677-55382012000400011","article-title":"Twenty-five milligrams of clomiphene citrate presents positive effect on treatment of male testosterone deficiency\u2014A prospective study","volume":"38","author":"Averbeck","year":"2012","journal-title":"Int. Braz. J. Urol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4172\/2161-038X.1000155","article-title":"Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men","volume":"4","author":"Bendre","year":"2015","journal-title":"Reprod. Syst. Sex. Disord."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/JU.0000000000002437","article-title":"Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy","volume":"207","author":"Ory","year":"2022","journal-title":"J. Urol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1532-5415.1995.tb05534.x","article-title":"Polycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levels","volume":"43","author":"Drinka","year":"1995","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis","volume":"95","author":"Murad","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse Events Associated With Testosterone Replacement in Middle-Aged and Older Men: A Meta-Analysis of Randomized, Placebo-Controlled Trials","volume":"60","author":"Calof","year":"2005","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2014.e11","DOI":"10.1016\/j.fertnstert.2008.03.036","article-title":"Azoospermia after treatment with clomiphene citrate in patients with oligospermia","volume":"90","author":"Pasqualotto","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cen.12092","article-title":"The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism","volume":"78","author":"Aftab","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/andr.13373","article-title":"Selective modulation of estrogen receptor in obese men with androgen deficiency: A systematic review and meta-analysis","volume":"11","author":"Tienforti","year":"2023","journal-title":"Andrology"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Selvam, M.K.P., Baskaran, S., Tannenbaum, J., Greenberg, J., Shalaby, H.Y., Hellstrom, W.J.G., and Sikka, S.C. (2023). Clomiphene Citrate in the Management of Infertility in Oligospermic Obese Men with Hypogonadism: Retrospective Pilot Study. Medicina, 59.","DOI":"10.3390\/medicina59111902"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bju.13337","article-title":"Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: Restoration instead of replacement","volume":"117","author":"Kim","year":"2016","journal-title":"BJU Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4103\/ijem.ijem_3_22","article-title":"Role of Aromatase Inhibitors in Managing Hypogonadism in Adult Males Related to Obesity and Aging: A Systematic Review and Meta-Analysis","volume":"26","author":"Dutta","year":"2022","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Colleluori, G., Chen, R., Turin, C.G., Vigevano, F., Qualls, C., Johnson, B., Mediwala, S., Villareal, D.T., and Armamento-Villareal, R. (2020). Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00277"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.21037\/tau-20-919","article-title":"Efficacy of anastrozole in the treatment of hypogonadal, subfertile men with body mass index \u226525 kg\/m2","volume":"10","author":"Shah","year":"2021","journal-title":"Transl. Androl. Urol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e12633","DOI":"10.1111\/and.12633","article-title":"Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men","volume":"49","year":"2017","journal-title":"Andrologia"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bju.14390","article-title":"Combination therapy with clomiphene citrate and anastrozole is a safe and effective alternative for hypoandrogenic subfertile men","volume":"122","author":"Alder","year":"2018","journal-title":"BJU Int."},{"key":"ref_132","first-page":"e13759","article-title":"Efficiency of intracavernosal alprostadil and oral clomiphene citrate combination treatment in penile vasculogenic erectile dysfunction patients accompanied by late-onset hypogonadism","volume":"52","author":"Balasar","year":"2020","journal-title":"Andrologia"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.fertnstert.2009.01.117","article-title":"Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: A randomized controlled trial","volume":"93","author":"Ghanem","year":"2010","journal-title":"Fertil. Steril."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1233\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:59:00Z","timestamp":1760111940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":133,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ph17091233"],"URL":"https:\/\/doi.org\/10.3390\/ph17091233","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]}}}